It’s back to school time. Despite the warmer weather, this time of year can also have you headed back to the doctor’s office. In a FOX 32 special report, Sylvia Perez takes a look at new tools to fight a very common and deadly virus.
We all know about cold and flu season. But what about RSV season?
Bartlett adds approximately 2% of all infants are also hospitalized every year due to an RSV infection and around 200 children die from it, making RSV the most common reason a child is admitted to the hospital."There’s around 150,000 to 180,000 hospitalizations every year and about 14,000 deaths. So that’s pretty important in terms of a virus causing outcomes like that," Aziz said.
"So what we have coming, hopefully soon for the infants, is a monoclonal antibody. So instead of teaching the body’s immune system how to fight off an infection, we actually give the injection of the antibodies themselves," Bartlett says. As for the impact the two new vaccines would have on seniors’ health, that depends on how many decide to get the vaccine and also have access to it.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Flu, Covid and RSV: Preventing another 'Tripledemic'As summer nears its end and the school year begins, it's a good time to think about getting those fall vaccinations against viruses that circulate in colder weather. A so-called 'Tripledemic' of Covid-19, the flu and RSV spread throughout the country last winter. To prevent a repeat, health officials are encouraging everyone to get vaccinated against Covid-19 and the flu, and now there are new protections against RSV. CBS News Bay Area's Ryan Yamamoto asks Dr. Jorge Salinas, infectious diseases specialist at Stanford Health Care, about the recommended vaccines
Read more »
FDA approves 1st maternal RSV vaccine to help protect infantsThe U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against respiratory syncytial virus (RSV).
Read more »
US FDA approves Pfizer's maternal RSV vaccine to protect infantsThe U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.
Read more »
FDA approves first RSV vaccine for pregnancy to protect newbornsExpectant parents could soon have another new option this fall to protect their newborns from RSV, the most common cause of hospitalization in American infants.
Read more »
FDA approves Pfizer maternal RSV vaccine for infantsPfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.
Read more »